These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6435655)

  • 1. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
    Gath I; Weidenfeld J; Collins GI; Hadad H
    Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
    Klotz U; Ziegler G; Ludwig L; Reimann IW
    J Clin Pharmacol; 1985 Sep; 25(6):400-6. PubMed ID: 2865275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
    Forster A; Juge O; Louis M; Nahory A
    Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the effects of midazolam on phrenic nerve activity in the dog by Ro 15-1788 and Ro 15-3505.
    Gordon G; Grundy EM; Al-Khudhairi D; Anderson DJ; Whitwam JG
    Br J Anaesth; 1984 Oct; 56(10):1161-5. PubMed ID: 6433950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons.
    Witkin JM; Barrett JE
    Life Sci; 1985 Oct; 37(17):1587-95. PubMed ID: 2932617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonistic action of a benzodiazepine antagonist: effects of Ro 15-1788 and midazolam on hypertonic NaCl intake.
    Tang M; Soroka S; Falk JL
    Pharmacol Biochem Behav; 1983 Jun; 18(6):953-5. PubMed ID: 6136990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midazolam-induced increase in NaCl solution ingestion: differential effect of the benzodiazepine antagonists Ro 15-1788 and CGS 8216.
    Falk JL; Tang M
    Pharmacol Biochem Behav; 1984 Dec; 21(6):965-8. PubMed ID: 6441170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative reversal of loss of vigilance following midazolam with the use of the antagonist flumazenil (Ro 15-1788). A comparative study with a placebo and the use of EEG-power spectra].
    Freye E; Fournell A
    Anaesthesist; 1988 Mar; 37(3):162-6. PubMed ID: 3132866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.
    Lauven PM; Schwilden H; Stoeckel H; Greenblatt DJ
    Anesthesiology; 1985 Jul; 63(1):61-4. PubMed ID: 2861765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors.
    Petersen EN; Braestrup C; Scheel-Krüger J
    Neurosci Lett; 1985 Feb; 53(3):285-8. PubMed ID: 2984608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
    Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
    Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
    Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.